Bradlow HL - Search Results

1

Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells.

Telang NT, Suto A, Wong GY, Osborne MP, Bradlow HL. Telang NT, et al. Among authors: bradlow hl. J Natl Cancer Inst. 1992 Apr 15;84(8):634-8. doi: 10.1093/jnci/84.8.634. J Natl Cancer Inst. 1992. PMID: 1556774

2

Effect of tamoxifen on mammary preneoplasia: relevance to chemopreventive intervention.

Telang NT, Bradlow HL, Osborne MP. Telang NT, et al. Among authors: bradlow hl. Cancer Detect Prev. 1994;18(4):313-21. Cancer Detect Prev. 1994. PMID: 7982241

3

Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk.

Osborne MP, Bradlow HL, Wong GY, Telang NT. Osborne MP, et al. Among authors: bradlow hl. J Natl Cancer Inst. 1993 Dec 1;85(23):1917-20. doi: 10.1093/jnci/85.23.1917. J Natl Cancer Inst. 1993. PMID: 8230281

4

Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent.

Tiwari RK, Guo L, Bradlow HL, Telang NT, Osborne MP. Tiwari RK, et al. Among authors: bradlow hl. J Natl Cancer Inst. 1994 Jan 19;86(2):126-31. doi: 10.1093/jnci/86.2.126. J Natl Cancer Inst. 1994. PMID: 8271295

5

Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells.

Suto A, Bradlow HL, Wong GY, Osborne MP, Telang NT. Suto A, et al. Among authors: bradlow hl. Breast Cancer Res Treat. 1993 Sep;27(3):193-202. doi: 10.1007/BF00665689. Breast Cancer Res Treat. 1993. PMID: 8312577

6

Genotoxic damage and aberrant proliferation in mouse mammary epithelial cells.

Telang NT, Suto A, Bradlow HL, Wong GY, Osborne MP. Telang NT, et al. Among authors: bradlow hl. Recent Prog Horm Res. 1993;48:481-8. doi: 10.1016/b978-0-12-571148-7.50023-3. Recent Prog Horm Res. 1993. PMID: 8441857 No abstract available.

7

2-hydroxyestrone: the 'good' estrogen.

Bradlow HL, Telang NT, Sepkovic DW, Osborne MP. Bradlow HL, et al. J Endocrinol. 1996 Sep;150 Suppl:S259-65. J Endocrinol. 1996. PMID: 8943806 Review.

8

Negative growth regulation of oncogene-transformed mammary epithelial cells by tumor inhibitors.

Telang NT, Inoue S, Bradlow HL, Osborne MP. Telang NT, et al. Among authors: bradlow hl. Adv Exp Med Biol. 1997;400A:409-18. doi: 10.1007/978-1-4615-5325-0_55. Adv Exp Med Biol. 1997. PMID: 9547584

9

Alteration of oestradiol metabolism in myc oncogene-transfected mouse mammary epithelial cells.

Telang NT, Arcuri F, Granata OM, Bradlow HL, Osborne MP, Castagnetta L. Telang NT, et al. Among authors: bradlow hl. Br J Cancer. 1998 May;77(10):1549-54. doi: 10.1038/bjc.1998.255. Br J Cancer. 1998. PMID: 9635827 Free PMC article.

10

Persistent estrogen responsiveness of ras oncogene-transformed mouse mammary epithelial cells.

Suto A, Bradlow HL, Wong GY, Osborne MP, Telang NT. Suto A, et al. Among authors: bradlow hl. Steroids. 1992 Jun;57(6):262-8. doi: 10.1016/0039-128x(92)90058-h. Steroids. 1992. PMID: 1440696

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters